Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOracle Power Regulatory News (ORCP)

Share Price Information for Oracle Power (ORCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.03
Bid: 0.028
Ask: 0.032
Change: 0.00 (0.00%)
Spread: 0.004 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.03
ORCP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Placing & Exercise Of Warrants

28 Dec 2017 07:00

RNS Number : 3986A
Oracle Power PLC
28 December 2017
 

 28 December 2017

Oracle Power PLC

("Oracle" or "the Company")

 

 

Equity Placing at 2.3p per Ordinary Share

Exercise of Warrants

 

Oracle Power PLC (AIM:ORCP), the UK energy developer of a combined lignite coal mine and mine mouth power plant located in the south-eastern Sindh Province of Pakistan, announces that it has issued a total of 27,023,652 ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares") at a price of 2.3 pence per share, representing an approximate premium of 20% to the closing mid-market price on 27 December 2017, pursuant to an equity fundraising. In addition, the Company also announces that Brandon Hill Capital Limited ("Brandon Hill"), the Company's broker, has exercised warrants held over 23,076,920 Ordinary Shares.

 

Equity placing and warrant exercise

The Company has raised £621,544 before costs by way of a placing of 27,023,652 new Ordinary Shares at a price of 2.3p per Ordinary Share to a new investor and the Company's joint broker, Brandon Hill, (the "Placing").

 

In addition, Brandon Hill has also exercised warrants held over 23,076,920 Ordinary Shares, at an exercise price of 0.65 pence per Ordinary Share (the "Exercise Price"), resulting in gross proceeds of £150,000 being receivable by the Company (the "Warrant Exercise"). The warrants were issued to Brandon Hill on 2 March 2015 at the Exercise Price, as remuneration for its role in a placing for the Company at that time. These warrants were due to expire in Q1 2018.

 

The proceeds of the Placing and the Warrant Exercise will provide Oracle with funds to repay the drawn principal and outstanding interest balance on the loan facility made available by Brandon Hill (announced on 25 September 2017) of £471,544, and will provide general working capital as the Company looks to move towards financial close on the basis of the Memorandum of Understanding with two major Chinese State Owned Enterprises, announced on 21 November 2017.

 

As part of the Placing, Brandon Hill has agreed to subscribe for 13,980,174 Ordinary Shares. Following the issue of the Ordinary Shares pursuant to the Placing and Warrant Exercise, Brandon Hill, together with its parent company, Optima Worldwide Group PLC, will hold 161,424,312 Ordinary Shares, representing 16.78 per cent of the enlarged issued share capital of the Company.

 

Related party transaction

Brandon Hill, in aggregate with its parent company, Optima Worldwide Group PLC, is a substantial shareholder of the Company. Accordingly, Brandon Hill's participation in the Placing constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The directors of the Company consider, having consulted with the Company's nominated adviser, Grant Thornton UK LLP, that the terms of this transaction are fair and reasonable insofar as its shareholders are concerned.

 

 Shahrukh Khan, CEO of Oracle, said:

 "We are pleased to announce the equity placing at a healthy premium to the current market share price, which will allow us to repay the outstanding loan balance to Brandon Hill and will strengthen the Company's balance sheet as we move into 2018 and ahead of targeting financial close."

 

 

Settlement and dealings

Application will be made for the 50,100,572 Ordinary Shares, issued pursuant to the Warrant Exercise and Placing, which will rank pari passu with the Company's existing issued Ordinary Shares, to be admitted to trading on AIM. Dealings on AIM are expected to commence at 8:00am on or around 5 January 2018 ("Admission").

 

Following Admission, for the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules ("DTRs"), Oracle will have 961,883,698 Ordinary Shares in issue with voting rights attached (one vote per Ordinary Share). The Company does not hold any shares in treasury. This figure of 961,883,698 ordinary shares may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the DTRs.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information please contact:

 

Oracle Power PLC

Shahrukh Khan

 

+44 (0) 203 580 4314

Brandon Hill Capital Limited

Oliver Stansfield

 

+44 (0)203 463 5000

Peterhouse Corporate Finance

Charles Goodfellow

 

+44 (0) 207 220 9791

Grant Thornton UK LLP

Salmaan Khawaja, Richard Tonthat, Daniel Bush 

 

+44 (0) 207 383 5100

Blytheweigh

Tim Blythe, Camilla Horsfall, Megan Ray

 

+44 (0) 207 138 3204

Fortbridge Consulting

Matt Beale, Bill Kemmery

+44 (0)7966 389196

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEFEFEFWFWSELE
Date   Source Headline
9th Jan 202011:05 amRNSSecond Price Monitoring Extn
9th Jan 202011:00 amRNSPrice Monitoring Extension
2nd Jan 20207:00 amRNSExercise of warrants and issue of equity
24th Dec 20197:00 amRNSAdmission and total voting rights
23rd Dec 201911:00 amRNSHolding(s) in Company
23rd Dec 20197:00 amRNSExercise of Warrants
20th Dec 20194:40 pmRNSSecond Price Monitoring Extn
20th Dec 20194:35 pmRNSPrice Monitoring Extension
20th Dec 201911:45 amRNSResult of General Meeting
17th Dec 20194:40 pmRNSSecond Price Monitoring Extn
17th Dec 20194:35 pmRNSPrice Monitoring Extension
16th Dec 20192:05 pmRNSSecond Price Monitoring Extn
16th Dec 20192:00 pmRNSPrice Monitoring Extension
16th Dec 20197:00 amRNSJoint Development Agreement Signed
13th Dec 20194:40 pmRNSSecond Price Monitoring Extn
13th Dec 20194:35 pmRNSPrice Monitoring Extension
12th Dec 20193:38 pmRNSShare Price movement
9th Dec 20191:00 pmRNSHolding(s) in Company
5th Dec 20197:00 amRNSPosting of Circular and Notice of General Meeting
4th Dec 20199:03 amRNSHolding(s) in Company
2nd Dec 20194:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20194:35 pmRNSPrice Monitoring Extension
2nd Dec 201912:01 pmRNSHolding(s) in Company
2nd Dec 20199:05 amRNSSecond Price Monitoring Extn
2nd Dec 20199:00 amRNSPrice Monitoring Extension
29th Nov 20195:00 pmRNSHolding(s) in Company
28th Nov 20192:05 pmRNSSecond Price Monitoring Extn
28th Nov 20192:00 pmRNSPrice Monitoring Extension
28th Nov 20199:05 amRNSSecond Price Monitoring Extn
28th Nov 20199:00 amRNSPrice Monitoring Extension
28th Nov 20198:10 amRNSProposed Fundraise of £700,000
19th Nov 20197:00 amRNSCPEC acknowledges Block VI
30th Sep 20191:15 pmRNSInterim Results and New Loan Agreement
29th Aug 20194:39 pmRNSHolding(s) in Company
21st Aug 20197:00 amRNSHolding(s) in Company
12th Aug 20197:00 amRNSEquity Placing
31st Jul 20193:00 pmRNSChange of Broker
16th Jul 20193:47 pmRNSResult of AGM
16th Jul 20191:52 pmRNSDirector Resignation
10th Jul 20197:00 amRNSDrawdown under Loan Agreement
2nd Jul 20197:00 amRNSDevelopment Funding Update
25th Jun 20198:45 amRNSPosting of Annual Report
18th Jun 20197:00 amRNSPreliminary Results
5th Jun 20197:00 amRNSOperational Update
30th May 20193:49 pmRNSLoan Agreement with Brandon Hill Capital Limited
16th May 20197:00 amRNSUpdate re Ceremonial Signing of MOU
3rd May 20197:00 amRNSUpdate re Ceremonial Signing of MOU
29th Apr 20197:00 amRNSCeremonial Signing of Memorandum of Understanding
27th Mar 20197:00 amRNSUpdate on Memorandum of Understanding
28th Feb 20192:15 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.